Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shaping of the tumor microenvironment: Stromal cells and vessels
Marzenna Blonska, Nitin Agarwal, Francisco Vega
Seminars in Cancer Biology (2015) Vol. 34, pp. 3-13
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Heparanase: From basic research to therapeutic applications in cancer and inflammation
Israël Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Drug Resistance Updates (2016) Vol. 29, pp. 54-75
Open Access | Times Cited: 197
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
Jana Plavá, Marina Cihova, Monika Buríková, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 149
Engineering Vascularized Organoid-on-a-Chip Models
Venktesh S. Shirure, Christopher C.W. Hughes, Steven C. George
Annual Review of Biomedical Engineering (2021) Vol. 23, Iss. 1, pp. 141-167
Open Access | Times Cited: 135
Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients
Pei-Chen Tsai, Tsung-Hua Lee, Kun-Chi Kuo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 72
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 50
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
Marina Weissmann, Gil Arvatz, Netanel A. Horowitz, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 3, pp. 704-709
Open Access | Times Cited: 107
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
Jack W. Singer, Suliman Al‐Fayoumi, Haiching Ma, et al.
Journal of Experimental Pharmacology (2016) Vol. Volume 8, pp. 11-19
Open Access | Times Cited: 103
Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo
Theresa Relation, Tai Yi, Adam J. Guess, et al.
Stem Cells (2018) Vol. 36, Iss. 6, pp. 915-924
Open Access | Times Cited: 66
Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
Shu‐Feng Zhou, Xiao‐Wu Chen
Drug Design Development and Therapy (2015), pp. 2941-2941
Open Access | Times Cited: 53
Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells
Theresa Relation, Massimo Dominici, Edwin M. Horwitz
Stem Cells (2017) Vol. 35, Iss. 5, pp. 1123-1130
Open Access | Times Cited: 51
Biomimetic on-a-chip platforms for studying cancer metastasis
Esak Lee, HH Song, Christopher S. Chen
Current Opinion in Chemical Engineering (2015) Vol. 11, pp. 20-27
Open Access | Times Cited: 50
Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment
Linbang Wang, Tao He, Jingkun Liu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
Damiënne Marcus, R. Lieverse, Carmen Klein, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1468-1468
Open Access | Times Cited: 36
Deciphering a crosstalk between biological cues and multifunctional nanocarriers in lung cancer therapy
Sharon George, Hendry Saju, Tharun Jaikumar, et al.
International Journal of Pharmaceutics (2025), pp. 125395-125395
Closed Access
Targeting gut microbiota: a potential therapeutic approach for tumor microenvironment in glioma
Q H Fan, Kaiqiang Meng, Xiaoping Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
Danilo Fiore, Luca Vincenzo Cappelli, Zhaoqi Liu, et al.
Cell Reports Medicine (2025), pp. 102029-102029
Open Access
Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth
Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, et al.
Cancer Research (2019) Vol. 80, Iss. 1, pp. 57-68
Open Access | Times Cited: 37
Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels
Weijie Zhong, Zhigang Zhu, Xin Xu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 36
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
Kuntal Bhowmick, Max Von Suskil, Omar S. Al‐Odat, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33091-e33091
Open Access | Times Cited: 3
Significance of host heparanase in promoting tumor growth and metastasis
Ganlin Zhang, Lilach Gutter-Kapon, Neta Ilan, et al.
Matrix Biology (2020) Vol. 93, pp. 25-42
Open Access | Times Cited: 27
The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer
Anita Chauhan, Sonam Agarwal, Marilyn Masih, et al.
Immunological Investigations (2023) Vol. 52, Iss. 7, pp. 856-878
Closed Access | Times Cited: 8
Role of tumor‑derived extracellular vesicles in cancer progression and their clinical applications (Review)
Fuhao Qiao, Peng Pan, Jiaping Yan, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 24
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells
Lei Shen, Shan‐Qiang Zhang, Lei Liu, et al.
Medical Science Monitor (2017) Vol. 23, pp. 223-237
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top